OPKO Health Statistics
Share Statistics
OPKO Health has 682.48M shares outstanding. The number of shares has increased by -2.08% in one year.
| Shares Outstanding | 682.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -2.14% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 309.23M |
| Failed to Deliver (FTD) Shares | 745 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 84.80M, so 12.43% of the outstanding shares have been sold short.
| Short Interest | 84.80M |
| Short % of Shares Out | 12.43% |
| Short % of Float | 27.42% |
| Short Ratio (days to cover) | 16.72 |
Valuation Ratios
The PE ratio is -6.01 and the forward PE ratio is -5.55.
| PE Ratio | -6.01 |
| Forward PE | -5.55 |
| PS Ratio | 1.31 |
| Forward PS | 1.4 |
| PB Ratio | 0.82 |
| P/FCF Ratio | -25.53 |
| PEG Ratio | n/a |
Enterprise Valuation
OPKO Health Inc. has an Enterprise Value (EV) of 1.37B.
| EV / Earnings | -7.23 |
| EV / Sales | 1.58 |
| EV / EBITDA | -20.85 |
| EV / EBIT | -8.7 |
| EV / FCF | -30.71 |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.55 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.18 |
| Total Debt / Capitalization | 15.22 |
| Cash Flow / Debt | -0.11 |
| Interest Coverage | -11.63 |
Financial Efficiency
Return on equity (ROE) is -0.14% and return on capital (ROIC) is -9.37%.
| Return on Equity (ROE) | -0.14% |
| Return on Assets (ROA) | -0.09% |
| Return on Capital (ROIC) | -9.37% |
| Revenue Per Employee | 219.72K |
| Profits Per Employee | -48.06K |
| Employee Count | 3.93K |
| Asset Turnover | 0.43 |
| Inventory Turnover | 8.3 |
Taxes
| Income Tax | 4.44M |
| Effective Tax Rate | -0.02 |
Stock Price Statistics
The stock price has increased by 56.25% in the last 52 weeks. The beta is 1.65, so OPKO Health 's price volatility has been higher than the market average.
| Beta | 1.65 |
| 52-Week Price Change | 56.25% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 45.24 |
| Average Volume (20 Days) | 4.00M |
Income Statement
In the last 12 months, OPKO Health had revenue of 863.50M and earned -188.86M in profits. Earnings per share was -0.25.
| Revenue | 863.50M |
| Gross Profit | 318.13M |
| Operating Income | -157.02M |
| Net Income | -188.86M |
| EBITDA | -65.52M |
| EBIT | -157.02M |
| Earnings Per Share (EPS) | -0.25 |
Balance Sheet
The company has 95.88M in cash and 326.56M in debt, giving a net cash position of -230.68M.
| Cash & Cash Equivalents | 95.88M |
| Total Debt | 326.56M |
| Net Cash | -230.68M |
| Retained Earnings | -2.01B |
| Total Assets | 2.26B |
| Working Capital | 417.98M |
Cash Flow
In the last 12 months, operating cash flow was -28.20M and capital expenditures -16.27M, giving a free cash flow of -44.47M.
| Operating Cash Flow | -28.20M |
| Capital Expenditures | -16.27M |
| Free Cash Flow | -44.47M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 36.84%, with operating and profit margins of -18.18% and -21.87%.
| Gross Margin | 36.84% |
| Operating Margin | -18.18% |
| Pretax Margin | -21.35% |
| Profit Margin | -21.87% |
| EBITDA Margin | -7.59% |
| EBIT Margin | -18.18% |
| FCF Margin | -5.15% |
Dividends & Yields
OPK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -17.01% |
| FCF Yield | -4.45% |
Analyst Forecast
The average price target for OPK is $3, which is 104.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 104.1% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.17 |
| Piotroski F-Score | 2 |